Insights & Resources

Public-sector procurement scandals show how lax vendor controls endanger taxpayer dollars. Learn key red flags and practical steps to reduce risk.

J.P. Morgan's Q1 2025 biopharma and medtech reports reveal larger deals, global growth and financial strategies shaping the life sciences industry.

Discover 10 surprising ways Texas’ rapid growth and advancements are reshaping industries, driving business innovation and creating new opportunities.

J.P. Morgan’s Q3 2024 Biopharma Report highlights robust venture investments, shifting licensing trends and a resurgence in IPO activity.

The medical technology, or medtech, industry is poised for a transformative year despite soft IPO activity the first half of 2024. Learn more here.

Facing limited resources and increasingly rapid technology advances, public service organizations must evolve their processes, systems and infrastructure to embrace existing shifts.

PCI DSS sets the standard for payment card security in higher education detailing compliance levels, reporting requirements and strategies to protect data.

By adopting best practices for fraud prevention and fostering a culture of transparency, NFPs can safeguard their resources and continue to make a positive impact.

If FinCEN’s proposed rule is adopted, SEC Registered Investment Advisers and Exempt Reporting Advisers would be subject to FinCEN’s AML and CFT requirements.

In a business sale, due diligence is critical to mitigate the risk of unexpected tax issues for buyers and sellers. Find out key components of tax due diligence.

After ransomware attacks severely impacted Atlanta, Oakland and other major cities across the nation, the need for government agencies to improve cyber risk should have been clear.

Weaver understands the regulations and best practices grant recipients need to follow to ensure compliance from Day One. Learn more.